Skip to main content

Day: January 18, 2024

TransCode Therapeutics Announces Pricing of $7.25 Million Public Offering

BOSTON, Jan. 18, 2024 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the pricing of a public offering of an aggregate of 5,942,623 shares of its common stock (or common stock equivalents) and warrants to purchase up to 11,885,246 shares of common stock at a combined public offering price of $1.22 per share (or per common stock equivalent) and accompanying warrants. The warrants will have an exercise price of $1.22 per share, will be exercisable immediately upon issuance and will expire three and one-half years from the date of issuance. The closing of the offering is expected to occur on or about January 22, 2024, subject to the satisfaction of customary closing conditions. H.C. Wainwright...

Continue reading

Brunswick Reports More Lithium Intersections on Globex Royalty Property

Figure 1Surface Map of the Mirage Project and Drill Holes Completed to Date – Brunswick ExplorationFigure 2Cross Sections A to A’ along Dyke MR-6 – Brunswick ExplorationROUYN-NORANDA, Quebec, Jan. 18, 2024 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to inform shareholders that Brunswick Exploration Inc. (TSXV-BRW, BRWXF- OTCQB) reports additional wide and multiple Li2O intersections on the Globex Lac Escale (Mirage) royalty property in the James Bay area of Quebec. On January 24, 2023, (click to access press release) Globex announced the sale of the property to Brunswick while...

Continue reading

JDE Peet’s enters into a long-term global licence agreement to manufacture, market and sell Caribou-branded consumer and foodservice coffee products

Press Release Amsterdam, 18 January 2024 JDE Peet’s (EURONEXT: JDEP), the world’s leading pure-play coffee and tea company by revenue, today announced it has signed a long-term global license agreement to manufacture, market and sell Caribou consumer and foodservice coffee products, excluding Caribou coffeehouses. The transaction, which is expected to close in the first quarter of 2024, provides JDE Peet’s a strong platform to expand its premium coffee portfolio in North America. Under the terms of the agreement, JDE Peet’s will acquire Caribou’s roasting operations in Minneapolis, Minnesota. The two companies have also reached a long-term strategic arrangement under which JDE Peet’s will supply coffee products for sale in Caribou’s coffeehouses. With over 800 coffeehouses in 11 countries, Caribou has made significant progress in its retail...

Continue reading

TCM Group A/S announces preliminary 2023 results with revenue and earnings above expectations.

  COMPANY ANNOUNCEMENT                                                                                                                     No. 185/2024 Tvis, 18 January 2024TCM Group A/S announces preliminary 2023 results with revenue and earnings above expectations. The preliminary and un-audited results for 2023 shows a revenue of DKK 1,111 million for the TCM Group A/S, which is DKK 46 million above the mid-point of the Company’s communicated guidance of between DKK 1,040 and 1,090 million. As a result of the increased revenue, preliminary earnings show an Adjusted EBIT of DKK 56 million, DKK 11 million above the mid-point of the guidance of an Adjusted EBIT of between DKK 40 and 50 million. CEO Torben Paulin: “The kitchen market in Denmark developed more positively than expected, particularly in the latter half of the fourth quarter...

Continue reading

Oilfield Equipment Market Size Worth USD 30.11 Billion in 2032 | Emergen Research

Increasing shale gas extraction, technological advancements in oilfield equipment, and redevelopment of mature oil wells are some of the major factors driving the oilfield equipment market revenue growth. Vancouver, Jan. 18, 2024 (GLOBE NEWSWIRE) — The global oilfield equipment market size was USD 20.65 billion in 2022 and is expected to register a revenue CAGR of 3.9% during the forecast period. Increasing shale gas extraction, technological advancements in oilfield equipment, and redevelopment of mature oil wells are some of the major factors driving the oilfield equipment market revenue growth. Technological advancements in oil well drilling equipment have been crucial in exploration of new oil and gas sources to cater to the growing global energy demand. Newer technologies are enabling more rapid energy production, and also...

Continue reading

BW Energy: Final results of the mandatory offer to acquire all shares in BW Energy Limited

Final results of the mandatory offer to acquire all shares in bw energy limited Reference is made to the mandatory offer by BW Group Limited (the “Offeror”) to acquire all outstanding shares (“Shares”) in BW Energy Limited (“BW Energy” or the “Company”) not already owned by the Offeror at an offer price of NOK 27.00 per share pursuant to the offer document (the “Offer Document”) dated 13 December 2023 (the “Offer”), and to the announcement dated 14 January 2024 of the preliminary results of the Offer following the expiry of the offer period (the “Offer Period”) on 12 January 2024 at 16:30 (CET). The Offer was accepted for a total of 30,589,179 Shares, which, taken together with the 103,202,470 Shares held by the Offeror at commencement of the Offer Period,...

Continue reading

Inside information, profit warning: WithSecure’s Cloud Annual Recurring Revenue (ARR) growth did not reach the outlook; WithSecure estimates to meet other areas of the 2023 outlook

WithSecure Corporation, Inside information, 18 January 2024 at 19:00 EET  Inside information, profit warning: WithSecure’s Cloud Annual Recurring Revenue (ARR) growth did not reach the outlook; WithSecure estimates to meet other areas of the 2023 outlook According to preliminary, unaudited figures, WithSecure estimates that the ARR growth of cloud products will be approximately 8 % from the previous year. Outlook for 2023 for cloud ARR growth was 18 – 24%. At the end of 2022, cloud ARR was EUR 80.2 million. Rationale for not meeting the cloud ARR outlook WithSecure cloud revenue is based on recurring subscriptions. The company collected a high volume of new subscriptions in the end of 2022, leading to a very high December 2022 ARR. Although the fourth quarter 2023 revenue was higher than in the other quarters of the year, a similar year-end...

Continue reading

Mortgage Rates Decrease to Lowest Level Since May of 2023

Primary Mortgage Market Survey®U.S. weekly average mortgage rates as of 01/18/2024MCLEAN, Va., Jan. 18, 2024 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 6.60 percent. “Mortgage rates decreased this week, reaching their lowest level since May of 2023,” said Sam Khater, Freddie Mac’s Chief Economist. “This is an encouraging development for the housing market and in particular first-time homebuyers who are sensitive to changes in housing affordability. However, as purchase demand continues to thaw, it will put more pressure on already depleted inventory for sale.” News FactsThe 30-year FRM averaged 6.60 percent as of January 18, 2024, down from last week when it averaged 6.66 percent. A year...

Continue reading

Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice

XHANCE significantly reduced both symptoms and sinus opacification in participants with chronic sinusitis (chronic rhinosinusitis) in two randomized controlled Phase 3 Clinical Trials (ReOpen1 and ReOpen2) FDA Supplemental New Drug Application Filed with Prescription Drug User Fee Act Target Goal Date of March 16, 2024 YARDLEY, Pa., Jan. 18, 2024 (GLOBE NEWSWIRE) —  Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced peer-reviewed publication of results from both ReOpen1 and ReOpen2 in the Journal of Allergy and Clinical Immunology: In Practice1. The ReOpen program evaluated XHANCE for treatment of adults with chronic sinusitis (chronic rhinosinusitis). A drug-device combination product, XHANCE® (fluticasone propionate) nasal spray uniquely...

Continue reading

Isobutane Market Size Worth USD 32.60 Billion in 2032 | Emergen Research

Increasing utilization as a propellant in aerosol products and supportive government laws and regulations promoting eco-friendly alternatives with minimum carbon footprint are key factors driving isobutane market revenue growth. Vancouver, Jan. 18, 2024 (GLOBE NEWSWIRE) — The global isobutane market size was USD 18.12 billion in 2022 and is expected to register a rapid revenue CAGR of 6.1% during the forecast period. Increasing utilization as a propellant in aerosol products and supportive government laws and regulations promoting eco-friendly alternatives with minimum carbon footprint are key factors driving market revenue growth. Isobutane is widely used in the automotive sector. For optimal engine performance, the inclusion of isobutane is crucial in high-octane gasoline. When combined with additional gasoline elements, the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.